I was intrigued by the detail in the US report - and scanned through the whole document. For those that are interested I felt the following pages were relevant: P176 - antivirals general P179 - 50/50 Relenza/Tamiflu stockpile rebalance in future- change from 20/80 P186 Seasonal flu 970/975 Resistant to Tamiflu P231 I/V antivirals P232 I/V Relenza P244 I/V Zanamivir (Relenza) P262 Tamiflu resistance P265 Concern re Tamiflu reistance 9/1700 H1N1 strains resistant, effectively 100% seasonal strains.
As you say Eric - why wasnt it publicised??
Regards Kangaroo1
BTA Price at posting:
$2.93 Sentiment: Hold Disclosure: Held
